NGeniuS讓你感受前所未有的INGENIOUS。 自動化的未來式你跟上了嗎?

瞭解更多關於Biomek NGeniuS

若時間可轉換為等值貨幣 自動化移液處理系統便是能持續增值的黃金。

適用於次一代定序 (NGS) 工作流程的靈活自動化液體處理解決方案

Strike Workflow Gold

自動化哥倆好
Biomek系列自動化工作站與Echo移液處理系統

瞭解更多關於可規模化移液的自動化方法

小而精緻,大有可為。
隆重介紹:新型Allegra V-15R桌上型離心機

瞭解更多關於Allegra V-15R

繼承CytoFLEX的智能與小巧
用科技與創新 將分選化繁為簡

瞭解更多關於CytoFLEX SRT

The Beckman Coulter Life Sciences Difference

Beckman Coulter's commitment to your research dates back to our origin in 1935. For more than 80 years, we have been a trusted partner for laboratory professionals, helping to advance scientific research and patient care. Beckman Coulter Life Sciences and Beckman.com is a global resource for millions of life science researchers, industrial and environmental technicians, and pharmaceutical and biomedical scientists.

Learn more

Latest news & updates

Press Release

Beckman Coulter Life Sciences Achieves Industry-First Reagent Certification to Help Prepare Labs for IVDR and to Clear Confusion

INDIANAPOLIS – (April 17, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, is leading the way to help laboratories prepare for critical upgrades to comply with the new In Vitro Diagnostic Medical Devices Regulation (IVDR), and to clear up confusion for laboratories that will soon be governed by IVDR.

Read more
Press Release

Beckman Coulter Life Sciences Completes First Phase of Colorado Research and Development Hub with Grand Opening of $10 Million Loveland Offices

LOVELAND, CO – (January 19, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, further strengthens its commitment to the greater Loveland, Colorado community with the completion of the first phase of its new research and development hub.

Read more
Press Release

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

INDIANAPOLIS – (October 31, 2022) – More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System. The company continues building a robust demonstrated application library as it announces an application development agreement with Pillar Biosciences, which specializes in developing and commercializing IVD & RUO NGS testing solutions that help research to optimize selection of precision therapies for cancer patients, from tumor profiling to therapy selection, and recurrence monitoring.  

Read more